Display Settings:

Format

Send to:

Choose Destination
    Immunol Invest. 2012;41(3):249-60. Epub 2012 Jan 5.

    Tolerogenic DNA vaccine for prevention of autoimmune ovarian disease.

    Source

    State Key Laboratory for Agro-Biotechnology, Key Laboratory of Microbiological Resources and Applications of the Ministry of Agriculture, College of Biological Science, China Agricultural University, Beijing 100193, China. kymin1012@163.com

    Abstract

    DNA vaccines have been widely used to induce immune responses against molecular targets. In this study, we explored the possibility of using DNA vaccine combined with the immunosuppressant FK506 (tacrolimus) to antigen-specifically suppress unwanted immune responses and prevent autoimmune ovarian disease. To that end, we immunized C57BL/6 mice with a DNA vaccine encoding mouse zona pellucida 3 (ZP3) together with FK506. The immunization induced ZP3-specific CD4(+)CD25(+)Foxp3(+) regulatory T cells (Treg), which suppressed the induction of ZP3-specific delayed-type hypersensitivity in the animals. Significantly, the immunization also protected the animals from experimentally induced autoimmune ovarian disease. These results suggest that DNA vaccination in the presence of FK506 may be used to induce Treg cells and prevent AOD.

    PMID:
    22221010
    [PubMed - in process]

      Supplemental Content

      Icon for Informa Healthcare

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk